1937 related articles for article (PubMed ID: 29045477)
1. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
2. Tubastatin alleviates epidural fibrosis via negatively targeting TGFβ/PI3K/Akt pathway.
Tao L; Wu L; Ge Y
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):231-236. PubMed ID: 38678601
[TBL] [Abstract][Full Text] [Related]
3. Eupatilin inhibits pulmonary fibrosis by activating Sestrin2/PI3K/Akt/mTOR dependent autophagy pathway.
Gong H; Lyu X; Liu Y; Peng N; Tan S; Dong L; Zhang X
Life Sci; 2023 Dec; 334():122218. PubMed ID: 37918625
[TBL] [Abstract][Full Text] [Related]
4. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes.
Choi SY; Ryu Y; Kee HJ; Cho SN; Kim GR; Cho JY; Kim HS; Kim IK; Jeong MH
Vascul Pharmacol; 2015 Sep; 72():130-40. PubMed ID: 25921924
[TBL] [Abstract][Full Text] [Related]
5. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
6. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
[No Abstract] [Full Text] [Related]
7. TGF-β1 induces tissue factor expression in human lung fibroblasts in a PI3K/JNK/Akt-dependent and AP-1-dependent manner.
Wygrecka M; Zakrzewicz D; Taborski B; Didiasova M; Kwapiszewska G; Preissner KT; Markart P
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):614-27. PubMed ID: 22771387
[TBL] [Abstract][Full Text] [Related]
8. Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib.
Bourne MH; Kottom TJ; Hebrink DM; Choudhury M; Leof EB; Limper AH
Cells; 2021 Dec; 10(12):. PubMed ID: 34944010
[TBL] [Abstract][Full Text] [Related]
9. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression.
Liu MW; Su MX; Tang DY; Hao L; Xun XH; Huang YQ
BMC Pulm Med; 2019 Feb; 19(1):35. PubMed ID: 30744607
[TBL] [Abstract][Full Text] [Related]
10. Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice.
Pan L; Cheng Y; Yang W; Wu X; Zhu H; Hu M; Zhang Y; Zhang M
Inflammation; 2023 Aug; 46(4):1531-1542. PubMed ID: 37160579
[TBL] [Abstract][Full Text] [Related]
11. Isoliquiritigenin inhibits TGF-β1-induced fibrogenesis through activating autophagy via PI3K/AKT/mTOR pathway in MRC-5 cells.
He J; Peng H; Wang M; Liu Y; Guo X; Wang B; Dai L; Cheng X; Meng Z; Yuan L; Cai F; Tang Y
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):810-820. PubMed ID: 32638014
[TBL] [Abstract][Full Text] [Related]
12. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559
[TBL] [Abstract][Full Text] [Related]
13. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
14. Aspirin alleviates pulmonary fibrosis through PI3K/AKT/mTOR-mediated autophagy pathway.
Peng J; Xiao X; Li S; Lyu X; Gong H; Tan S; Dong L; Sanders YY; Zhang X
Exp Gerontol; 2023 Feb; 172():112085. PubMed ID: 36623738
[TBL] [Abstract][Full Text] [Related]
15. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
16. Trichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway.
Li LF; Lee CS; Lin CW; Chen NH; Chuang LP; Hung CY; Liu YY
PLoS One; 2017; 12(2):e0172571. PubMed ID: 28234968
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
19. A critical role for the mTORC2 pathway in lung fibrosis.
Chang W; Wei K; Ho L; Berry GJ; Jacobs SS; Chang CH; Rosen GD
PLoS One; 2014; 9(8):e106155. PubMed ID: 25162417
[TBL] [Abstract][Full Text] [Related]
20. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]